175 related articles for article (PubMed ID: 7036761)
1. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine.
Simpson GM; White KL; Boyd JL; Cooper TB; Halaris A; Wilson IC; Raman EJ; Ruther E
Am J Psychiatry; 1982 Mar; 139(3):358-60. PubMed ID: 7036761
[No Abstract] [Full Text] [Related]
2. Depression in children: relationship between plasma imipramine levels and response.
Preskorn SH; Weller EB; Weller RA
J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
[TBL] [Abstract][Full Text] [Related]
3. The relationship of therapeutic response to antidepressant plasma levels: an update.
Friedel RO
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):37-43. PubMed ID: 7174630
[No Abstract] [Full Text] [Related]
4. Imipramine blood levels and clinical outcome.
Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
[TBL] [Abstract][Full Text] [Related]
5. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
[TBL] [Abstract][Full Text] [Related]
6. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
[TBL] [Abstract][Full Text] [Related]
8. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
[TBL] [Abstract][Full Text] [Related]
9. A new antidepressant agent: amitriptyline-N-oxide.
Borromei A
Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
[No Abstract] [Full Text] [Related]
10. Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.
Heijnen WT; van den Broek WW; Mulder PG; Birkenhäger TK
J Psychopharmacol; 2010 Apr; 24(4):559-63. PubMed ID: 19028834
[TBL] [Abstract][Full Text] [Related]
11. A double blind comparison of the efficacy and safety of trazodone and imipramine in endogenous depression.
Al-Yassiri MM; Ankier SI; Bridges PK
J Affect Disord; 1983 Nov; 5(4):333-40. PubMed ID: 6229564
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels and antidepressive effect of imipramine.
Gram LF; Reisby N; Ibsen I; Nagy A; Dencker SJ; Bech P; Petersen GO; Christiansen J
Clin Pharmacol Ther; 1976 Mar; 19(3):318-24. PubMed ID: 770049
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of bupropion in elderly patients: preliminary observations.
Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
[TBL] [Abstract][Full Text] [Related]
15. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
Bohacek N; Ravic M; Bizière K
Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with imipramine and mianserin. A controlled pilot study.
Lauritzen L; Clemmesen L; Klysner R; Loldrup D; Lunde M; Schaumburg E; Waarst S; Bech P
Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957
[TBL] [Abstract][Full Text] [Related]
17. A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients.
Vermeiden M; Mulder PG; van den Broek WW; Bruijn JA; Birkenhäger TK
J Psychiatr Res; 2013 Oct; 47(10):1337-42. PubMed ID: 23800419
[TBL] [Abstract][Full Text] [Related]
18. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
[No Abstract] [Full Text] [Related]
19. Efficacy of imipramine in psychotic versus nonpsychotic depression.
Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
[TBL] [Abstract][Full Text] [Related]
20. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
